Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions

Journal of Ginseng Research - Tập 42 - Trang 123-132 - 2018
Padmanaban Mohanan1, Sathiyamoorthy Subramaniyam2, Ramya Mathiyalagan1, Deok-Chun Yang1,2
1Graduate School of Biotechnology and Ginseng Bank, College of Life Sciences, Kyung Hee University, Suwon, Republic of Korea
2Department of Oriental Medicinal Biotechnology, College of Life Science, Kyung Hee University, Suwon, Republic of Korea

Tài liệu tham khảo

Kim, 2015, Biosynthesis and biotechnological production of ginsenosides, Biotechnol Adv, 33, 717, 10.1016/j.biotechadv.2015.03.001 Lee, 2014, A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases, J Ginseng Res, 38, 161, 10.1016/j.jgr.2014.03.001 Lan, 2011, Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition, Biochem Pharmacol, 82, 148, 10.1016/j.bcp.2011.04.001 Ahmed, 2016, Ginsenoside Rb1 as a neuroprotective agent: a review, Brain Res Bull, 125, 30, 10.1016/j.brainresbull.2016.04.002 Koh, 2017, Ginsenoside Rg1 suppresses early stage of adipocyte development via activation of C/EBP homologous protein-10 in 3T3-L1 and attenuates fat accumulation in high fat diet-induced obese zebrafish, J Ginseng Res, 41, 23, 10.1016/j.jgr.2015.12.005 Zhao, 2014, Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signaling transduction factors in the NG108-15 murine neuroglial cell line, Molecules, 19, 16925, 10.3390/molecules191016925 Chen, 2016, Anticancer activities of protopanaxadiol- and protopanaxatriol-type ginsenosides and their metabolites, Evid Based Complement Alternat Med, 2016, 10.1155/2016/5738694 Xu, 2016, The antitumor activity study of ginsenosides and metabolites in lung cancer cell, Am J Transl Res, 8, 1708 Nag, 2012, Ginsenosides as anticancer agents: in vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of action, Front Pharmacol, 3, 1, 10.3389/fphar.2012.00025 Choi, 2013, Biochemical basis of cancer chemoprevenion and or chemotherapy with ginsenosides, Int J Mol Med, 32, 1227, 10.3892/ijmm.2013.1519 Nabavi, 2015, Ginsenoside Rd and ischemic stroke; a short review of literatures, J Ginseng Res, 39, 299, 10.1016/j.jgr.2015.02.002 Yang, 2015, A review of biotransformation and pharmacology of ginsenoside compound K, Fitoterapia, 100, 208, 10.1016/j.fitote.2014.11.019 Jin, 2015, Ginseng consumption and risk of cancer: a meta-analysis, J Ginseng Res, 40, 269, 10.1016/j.jgr.2015.08.007 WHO fact sheet. Cardiovascular diseases (CVDs) [Internet]. 2016 September [cited 2016 Dec 29]. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/. Tousoulis, 2012, The role of nitric oxide on endothelial function, Curr Vasc Pharmacol, 10, 4, 10.2174/157016112798829760 Pirillo, 2013, LOX-1, OxLDL, and atherosclerosis, Mediators Inflamm, 2013, 152786, 10.1155/2013/152786 Hien, 2010, Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase, Toxicol Appl Pharmacol, 246, 171, 10.1016/j.taap.2010.05.008 Ganguly, 2015, Role of homocysteine in the development of cardiovascular disease, Nutr J, 14, 6, 10.1186/1475-2891-14-6 Xu, 2011, The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine, J Vasc Surg, 53, 156, 10.1016/j.jvs.2010.06.170 Yu, 2007, Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor, Biochem Biophys Res Commun, 353, 764, 10.1016/j.bbrc.2006.12.119 Ucuzian, 2010, Molecular mediators of angiogenesis, J Burn Care Res, 31, 158, 10.1097/BCR.0b013e3181c7ed82 Kwok, 2012, Stereoisomers ginsenosides-20(S)-Rg(3) and -20(R)-Rg(3) differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma, Biochem Pharmacol, 83, 893, 10.1016/j.bcp.2011.12.039 Chan, 2009, Role of MicroRNA-214 in ginsenoside-Rg1-induced angiogenesis, Eur J Pharm Sci, 38, 370, 10.1016/j.ejps.2009.08.008 Duan, 2015, MicroRNA-214 is upregulated in heart failure patients and suppresses XBP1-mediated endothelial cells angiogenesis, J Cell Physiol, 230, 1964, 10.1002/jcp.24942 Kim, 2012, Cardiovascular aiseases and Panax ginseng: a review on molecular mechanisms and medical applications, J Ginseng Res, 36, 16, 10.5142/jgr.2012.36.1.16 Heineke, 2006, Regulation of cardiac hypertrophy by intracellular signaling pathways, Nat Rev Mol Cell Biol, 7, 589, 10.1038/nrm1983 Jiang, 2007, Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat, J Ethnopharmacol, 111, 567, 10.1016/j.jep.2007.01.006 Zhang, 2013, The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis, J Cardiovasc Pharmacol, 62, 50, 10.1097/FJC.0b013e31828f8d45 Zhu, 2009, Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis, J Cell Biochem, 108, 117, 10.1002/jcb.22233 Wang, 2015, Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B-cell lymphoma/B-cell lymphoma-associated X protein pathway, Mol Med, 11, 4518 Wu, 2011, Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats, Mol Biol Rep, 38, 4327, 10.1007/s11033-010-0558-4 Sun, 2016, Roles and mechanisms of ginsenoside on cardiovascular diseases: progress and perspectives, Sci China Life, 59, 292, 10.1007/s11427-016-5007-8 Huang, 2012, Inhibitory effect of ginsenoside Rg1 on vascular smooth muscle cell proliferation induced by PDGF-BB is involved in nitric oxide formation, Evid Based Complement Alternat Med, 2012, 314395, 10.1155/2012/314395 Guo, 2011, Rb1 postconditioning attenuates liver warm ischemia–reperfusion injury through ROS–NO–HIF pathway, Life Sci, 88, 598, 10.1016/j.lfs.2011.01.022 Wong, 2015, Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview, Nat Prod Rep, 32, 256, 10.1039/C4NP00080C Lu, 2008, Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer, Chin J Integr Med, 14, 33, 10.1007/s11655-007-9002-6 Wang, 2015, Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway, Mol Med Rep, 12, 609, 10.3892/mmr.2015.3397 Shan, 2014, Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation, PLoS One, 9, e115401, 10.1371/journal.pone.0115401 Lo, 2011, Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells, J Med Food, 14, 1135, 10.1089/jmf.2010.1485 Jiang, 2011, Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway, World J Gastroenterol, 17, 3605, 10.3748/wjg.v17.i31.3605 Zhang, 2012, Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells, Mol Med Rep, 5, 1295 Zhang, 2015, 20(S)-Ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway, Drug Des Devel Ther, 9, 3969 Wu, 2015, Endoplasmic reticulum stress activation mediates Ginseng Rg3-induced anti-gallbladder cancer cell activity, Biochem Biophys Res Commun, 466, 369, 10.1016/j.bbrc.2015.09.030 Lee, 2012, Food Chem Toxicol, 50, 2565, 10.1016/j.fct.2012.01.005 Wang, 2014, 20(S)-Ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways, Tumour Biol, 35, 11985, 10.1007/s13277-014-2497-5 Junmin, 2015, Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity, J Tradit Chin Med, 35, 440 He, 2011, Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ss-catenin signaling, Int J Oncol, 38, 437, 10.3892/ijo.2010.858 Leung, 2007, Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor, Br J Pharmacol, 152, 207, 10.1038/sj.bjp.0707359 Yu, 2015, Ginsenoside Rg1 attenuates invasion and migration by inhibiting transforming growth factor-β1-induced epithelial to mesenchymal transition in HepG2 cells, Mol Med Rep, 11, 3167, 10.3892/mmr.2014.3098 Steward, 2013, Cancer chemoprevention: a rapidly evolving field, Br J Cancer, 109, 1, 10.1038/bjc.2013.280 Stejskalova, 2011, The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta, Curr Pharm Biotechnol, 12, 715, 10.2174/138920111795470994 Wang, 2008, Induction of cytochrome P450 1A1 expression by ginsenoside Rg1 and Rb1 in HepG2 cells, Eur J Pharmacol, 601, 73, 10.1016/j.ejphar.2008.10.057 Li, 2016, Ginsenoside exhibits concentration-dependent dual effects on HepG2 cell proliferation via regulation of c-Myc and HNF-4α, Eur J Pharmacol, 792, 26, 10.1016/j.ejphar.2016.10.017 WHO, 2016 Yuan, 2012, Ginseng and diabetes: the evidences from in vitro, animal and human studies, J Ginseng Res, 36, 27, 10.5142/jgr.2012.36.1.27 Hwang, 2010, Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells, Toxicol Appl Pharmacol, 242, 18, 10.1016/j.taap.2009.09.009 Shen, 2015, Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats, Physiol Rep, 3, e12453, 10.14814/phy2.12543 Xiong, 2010, Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats, Diabetes, 59, 2505, 10.2337/db10-0315 Kong, 2009, Anti-hypoxic effect of ginsenoside Rb1 on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo, Acta Pharmacol Sin, 30, 396, 10.1038/aps.2009.2 Chen, 2016, Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue, J Ginseng Res, 40, 351, 10.1016/j.jgr.2015.11.002 Lee, 2012, Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathway in insulin-resistant muscle cells, Phytother Res, 26, 1017, 10.1002/ptr.3686 Kim, 2010, Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells, Biol Pharm Bull, 33, 325, 10.1248/bpb.33.325 Shang, 2008, Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes, J Endocrinol, 198, 561, 10.1677/JOE-08-0104 Kim, 2016, Rg3 improves mitochondrial function and the expression of key genes involved in mitochondrial biogenesis in C2C12 myotubes, Diabetes Metab J, 40, 406, 10.4093/dmj.2016.40.5.406 Lee, 2011, Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes, Phytother Res, 25, 768, 10.1002/ptr.3322 Kim, 2015, The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice, Sci Rep, 5, 18325, 10.1038/srep18325 Park, 2008, 20(S)-Ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK, Biol Pharm Bull, 31, 748, 10.1248/bpb.31.748 Kim, 2010, Ginsenoside 20(R)-Rg3 stimulates glucose uptake in C2C12 myotubes via CaMKK–AMPK pathways, Food Sci Biotechnol, 19, 1277, 10.1007/s10068-010-0182-z Yu, 2016, Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model, J Cell Mol Med, 20, 623, 10.1111/jcmm.12739 Kim, 2007, Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus, Brain Res, 1136, 190, 10.1016/j.brainres.2006.12.047 Scholey, 2010, Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study, Psychopharmacology (Berl), 212, 345, 10.1007/s00213-010-1964-y Uttara, 2009, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options, Curr Neuropharmacol, 7, 65, 10.2174/157015909787602823 Skaper, 2012, The neurotrophin family of neurotrophic factors: an overview, Methods Mol Biol, 846, 1, 10.1007/978-1-61779-536-7_1 Zheng, 2009, NMDA-mediated and self-induced bdnf exon IV transcriptions are differentially regulated in cultured cortical neurons, Neurochem Int, 54, 385, 10.1016/j.neuint.2009.01.006 Liang, 2010, Ginsenosides Rb1 and Rg1 promote proliferation and expression of neurotrophic factors in primary Schwann cell cultures, Brain Res, 1357, 19, 10.1016/j.brainres.2010.07.091 Shi, 2010, Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice, J Alzheimers Dis, 19, 977, 10.3233/JAD-2010-1296 Jiang, 2012, Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus, Br J Pharmacol, 166, 1872, 10.1111/j.1476-5381.2012.01902.x Ardah, 2015, Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils, Neurobiol Dis, 74, 89, 10.1016/j.nbd.2014.11.007 O'Brien, 2011, Amyloid precursor protein processing and Alzheimer's disease, Annu Rev Neurosci, 34, 185, 10.1146/annurev-neuro-061010-113613 Chen, 2008, Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons, Brain Res, 1200, 99, 10.1016/j.brainres.2007.12.029 Shi, 2012, Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt, Biochim Biophys Acta, 1820, 453, 10.1016/j.bbagen.2011.12.005 Araki, 2016, Post-translational regulation of the β-secretase BACE1, Brain Res Bull, 126, 170, 10.1016/j.brainresbull.2016.04.009 Choi, 2016, BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides, J Ethnopharmacol, 190, 219, 10.1016/j.jep.2016.06.013 Chen, 2012, Ginsenoside Rg1 attenuates beta-amyloid generation via suppressing PPARgamma-regulated BACE1 activity in N2a-APP695 cells, Eur J Pharmacol, 675, 15, 10.1016/j.ejphar.2011.11.039 Wu, 2013, Ginsenoside Rg1 facilitates neural differentiation of mouse embryonic stem cells via GR-dependent signaling pathway, Neurochem Int, 62, 92, 10.1016/j.neuint.2012.09.016 Liu, 2014, Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth, Neural Regen Res, 9, 943, 10.4103/1673-5374.133137 Hao, 2011, Beneficial estrogen-like effects of ginsenoside Rb1, an active component of Panax ginseng, on neural 5-HT disposition and behavioral tasks in ovariectomized mice, Eur J Pharmacol, 659, 15, 10.1016/j.ejphar.2011.03.005 Lau, 2008, Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway, J Steroid Biochem Mol Biol, 108, 64, 10.1016/j.jsbmb.2007.06.005 Shohami, 2014, Novel approach to the role of NMDA receptors in traumatic brain injury, CNS Neurol Disord Drug Targets, 13, 567, 10.2174/18715273113126660196 Zhang, 2008, Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels, Eur J Pharmacol, 586, 90, 10.1016/j.ejphar.2007.12.037 Shen, 2007, NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils, Neurol Res, 29, 270, 10.1179/016164107X159144 Yang, 2014, Long-term ginsenoside Rg1 supplementation improves age-related cognitive decline by promoting synaptic plasticity associated protein expression in C57BL/6J mice, J Gerontol A Biol Sci Med Sci, 69, 282, 10.1093/gerona/glt091 Escobar, 2004, Neuropeptide Y gene expression is increased in the hypothalamus of older women, J Clin Endocrinol Metab, 89, 2338, 10.1210/jc.2003-031899 Gumbs, 2016, The effect of obesogenic diets on brain Neuropeptide Y, Physiol Behav, 162, 161, 10.1016/j.physbeh.2016.04.049 Lin, 2014, Ginseng panaxoside Rb1 reduces body weight in diet-induced obese mice, Cell Biochem Biophys, 68, 189, 10.1007/s12013-013-9688-3 Ye, 2016, Neuroprotective effects of ginsenosides on neural progenitor cells against oxidative injury, Mol Med Rep, 13, 3083, 10.3892/mmr.2016.4914 Ni, 2014, Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury, Molecules, 19, 3012, 10.3390/molecules19033012 Tabas, 2011, Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress, Nat Cell Biol, 13, 184, 10.1038/ncb0311-184 Liu, 2014, Ginsenoside Rb1 protects hippocampal neurons from high glucose-induced neurotoxicity by inhibiting GSK3beta-mediated CHOP induction, Mol Med Rep, 9, 1434, 10.3892/mmr.2014.1958 Liu, 2013, Neuroprotective effects of ginsenoside Rb1 on high glucose-induced neurotoxicity in primary cultured rat hippocampal neurons, PLoS One, 8, e79399, 10.1371/journal.pone.0079399